275 related articles for article (PubMed ID: 27519147)
1. The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease.
Ochoa-Repáraz J; Kasper LH
Transl Res; 2017 Jan; 179():126-138. PubMed ID: 27519147
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Gut-Brain Axis for the Control of CNS Inflammatory Demyelination: Immunomodulation by
Erturk-Hasdemir D; Ochoa-Repáraz J; Kasper DL; Kasper LH
Front Immunol; 2021; 12():662807. PubMed ID: 34025663
[TBL] [Abstract][Full Text] [Related]
3. CD39+ regulatory T cells attenuate allergic airway inflammation.
Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
[TBL] [Abstract][Full Text] [Related]
4. Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients.
Álvarez-Sánchez N; Cruz-Chamorro I; Díaz-Sánchez M; Lardone PJ; Guerrero JM; Carrillo-Vico A
Sci Rep; 2019 Feb; 9(1):2302. PubMed ID: 30783191
[TBL] [Abstract][Full Text] [Related]
5. Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood.
Yadav SK; Boppana S; Ito N; Mindur JE; Mathay MT; Patel A; Dhib-Jalbut S; Ito K
Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9318-E9327. PubMed ID: 29078267
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse.
Muls NG; Dang HA; Sindic CJ; van Pesch V
Mult Scler; 2015 Oct; 21(12):1533-45. PubMed ID: 25662347
[TBL] [Abstract][Full Text] [Related]
7. Fingolimod increases CD39-expressing regulatory T cells in multiple sclerosis patients.
Muls N; Dang HA; Sindic CJ; van Pesch V
PLoS One; 2014; 9(11):e113025. PubMed ID: 25411844
[TBL] [Abstract][Full Text] [Related]
8. The Gut Microbiome and Multiple Sclerosis.
Ochoa-Repáraz J; Kirby TO; Kasper LH
Cold Spring Harb Perspect Med; 2018 Jun; 8(6):. PubMed ID: 29311123
[TBL] [Abstract][Full Text] [Related]
9. Human CD39
Gu J; Ni X; Pan X; Lu H; Lu Y; Zhao J; Guo Zheng S; Hippen KL; Wang X; Lu L
Cell Mol Immunol; 2017 Jun; 14(6):521-528. PubMed ID: 27374793
[TBL] [Abstract][Full Text] [Related]
10. Gut reactions: How the blood-brain barrier connects the microbiome and the brain.
Logsdon AF; Erickson MA; Rhea EM; Salameh TS; Banks WA
Exp Biol Med (Maywood); 2018 Jan; 243(2):159-165. PubMed ID: 29169241
[TBL] [Abstract][Full Text] [Related]
11. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
12. IL-7 modulates in vitro and in vivo human memory T regulatory cell functions through the CD39/ATP axis.
Younas M; Hue S; Lacabaratz C; Guguin A; Wiedemann A; Surenaud M; Beq S; Croughs T; Lelièvre JD; Lévy Y
J Immunol; 2013 Sep; 191(6):3161-8. PubMed ID: 23966629
[TBL] [Abstract][Full Text] [Related]
13. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation.
Rissiek A; Baumann I; Cuapio A; Mautner A; Kolster M; Arck PC; Dodge-Khatami A; Mittrücker HW; Koch-Nolte F; Haag F; Tolosa E
J Autoimmun; 2015 Apr; 58():12-20. PubMed ID: 25640206
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome and the risk factors in central nervous system autoimmunity.
Ochoa-Repáraz J; Kasper LH
FEBS Lett; 2014 Nov; 588(22):4214-22. PubMed ID: 25286403
[TBL] [Abstract][Full Text] [Related]
15. CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma.
Wang LL; Tang HP; Shi GC; Wan HY; Tang W; Hou XX; Pan LN; Shi BY; Tao LQ
Mol Med Rep; 2013 Nov; 8(5):1432-8. PubMed ID: 24065069
[TBL] [Abstract][Full Text] [Related]
16. From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways.
Rogers GB; Keating DJ; Young RL; Wong ML; Licinio J; Wesselingh S
Mol Psychiatry; 2016 Jun; 21(6):738-48. PubMed ID: 27090305
[TBL] [Abstract][Full Text] [Related]
17. T
Choi J; Kim BR; Akuzum B; Chang L; Lee JY; Kwon HK
Front Immunol; 2022; 13():916066. PubMed ID: 35844606
[TBL] [Abstract][Full Text] [Related]
18. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
[TBL] [Abstract][Full Text] [Related]
19. Target tissue ectoenzyme CD39/CD73-expressing Foxp3+ regulatory T cells in patients with psoriasis.
Zhang HY; Yan KX; Huang Q; Ma Y; Fang X; Han L
Clin Exp Dermatol; 2015 Mar; 40(2):182-91. PubMed ID: 25284153
[TBL] [Abstract][Full Text] [Related]
20. Gut commensalism, cytokines, and central nervous system demyelination.
Telesford K; Ochoa-Repáraz J; Kasper LH
J Interferon Cytokine Res; 2014 Aug; 34(8):605-14. PubMed ID: 25084177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
